Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI

Launched by MONTREAL HEART INSTITUTE · Oct 5, 2017

Keywords

ClinConnect Summary

This clinical trial is investigating two different ways to monitor patients who develop a specific heart condition called left bundle branch block (LBBB) after undergoing a procedure to replace their aortic valve, known as transcatheter aortic valve implantation (TAVI). The researchers want to find out if using an advanced heart monitoring technique—an electrophysiology-guided algorithm—can do a better job at preventing serious issues like fainting, hospital stays, and death compared to the usual monitoring approach, which lasts for 30 days after the procedure.

To be eligible for this trial, participants must be at least 18 years old and have been diagnosed with a new case of LBBB after their TAVI procedure. However, individuals who already have certain heart devices, such as a pacemaker, or had prior heart block conditions before TAVI, will not be able to join. If you participate, you can expect to be closely monitored and receive care based on the study's findings, contributing valuable information that could help improve treatment for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥18 years
• • Informed consent to participate
• • Persistent new-onset LBBB after TAVI implantation (i.e. present at day 2)
• Exclusion Criteria:
• • Prior pacemaker or implantable cardioverter-defibrillator
• • Pre-existing right bundle branch block (RBBB) or LBBB (i.e., prior to TAVI)
• • Class I or IIA indication for PPM implantation according to management guidelines